These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes. Cesura AM; Imhof R; Takacs B; Galva MD; Picotti GB; Da Prada M J Neurochem; 1988 Apr; 50(4):1037-43. PubMed ID: 3126263 [TBL] [Abstract][Full Text] [Related]
8. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl]. Severina IS Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase by 7-chloro-4-nitrobenzofurazan. Fu RC; Liu XF; Chen SU J Neurochem; 1990 Sep; 55(3):813-8. PubMed ID: 2384754 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Fuller RW; Hemrick-Luecke SK J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853 [TBL] [Abstract][Full Text] [Related]
11. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase. Fuller RW; Hemrick-Luecke SK; Molloy BB Biochem Pharmacol; 1983 Apr; 32(7):1243-9. PubMed ID: 6847714 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain. Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528 [TBL] [Abstract][Full Text] [Related]
14. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol]. Schraven E; Reibert R Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783 [TBL] [Abstract][Full Text] [Related]
15. Absence of 2-phenylethylamine binding after monoamine oxidase inhibition in rat brain. Li XM; Juorio AV; Paterson IA; Boulton AA Eur J Pharmacol; 1992 Jan; 210(2):189-93. PubMed ID: 1601056 [TBL] [Abstract][Full Text] [Related]
16. [3H]Ro 19-6327: a reversible ligand and affinity labelling probe for monoamine oxidase-B. Cesura AM; Galva MD; Imhof R; Kyburz E; Picotti GB; Da Prada M Eur J Pharmacol; 1989 Mar; 162(3):457-65. PubMed ID: 2744079 [TBL] [Abstract][Full Text] [Related]
17. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro]. Gol'dina OA; Zagorevskiĭ VA; Lopatina KI; Sokolova TV; Gankina EM Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029 [TBL] [Abstract][Full Text] [Related]
18. Isoelectric analysis of 3H-pargyline-labelled monoamine oxidase in rat and carp. Obata T; Yamanaka Y; Sho S; Kinemuchi H Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(1):91-8. PubMed ID: 1980888 [TBL] [Abstract][Full Text] [Related]
19. Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Adem A; Jossan SS; Oreland L Neurosci Lett; 1989 Dec; 107(1-3):313-7. PubMed ID: 2616041 [TBL] [Abstract][Full Text] [Related]